Body weight is easy to measure. It is also one of the least informative ways to understand what is happening to the body over time.
Two people can weigh exactly the same and have very different physiology. One may have substantial muscle, little visceral fat and good metabolic health. Another may have less muscle, more visceral fat and significant insulin resistance. Their weight may be identical, but their health trajectories are not.
Body composition allows us to see that difference.
In longevity medicine, we are interested in how much lean tissue a person has, where body fat is stored, whether visceral fat is increasing or decreasing, whether muscle is being preserved during weight loss and whether strength and physical function are holding up with age.
These are not cosmetic measurements. They are part of understanding metabolic health, cardiovascular risk, bone health, physical reserve and the ability to remain strong and independent later in life.
What Body Composition Actually Means
Body composition describes the tissues that make up body weight rather than treating body weight as a single measurement.
The major components we care about clinically include:
- lean mass
- skeletal muscle distribution
- total fat mass
- body-fat percentage
- visceral adipose tissue
- regional fat distribution
- bone mineral content and bone density when measured by DEXA
Knowing that someone weighs 170 pounds tells us none of this.
It also does not tell us what changed when that person lost or gained ten pounds. Weight loss can represent fat loss, muscle loss, water loss or some combination of the three. Weight gain can represent increasing visceral fat, increasing muscle or both.
This is why body composition gives us information that a scale or BMI cannot.
Muscle Is More Than Something That Moves the Body
Skeletal muscle is an important metabolic and functional organ. It is one of the body's major sites of glucose disposal, plays an important role in insulin sensitivity and provides the physical reserve needed for mobility, recovery and independence.
As people age, muscle tends to decline unless there is enough reason for the body to preserve it. Inactivity, inadequate protein, illness, significant calorie restriction, poor metabolic health and hormonal changes can all contribute.
The loss may be gradual enough that it is easy to miss. Someone can maintain roughly the same weight for years while losing muscle and accumulating fat. The scale barely changes while body composition changes considerably.
For a deeper discussion, see Muscle Mass and Longevity: Strength, Metabolism, and Healthy Aging.
Muscle Function Matters Too
Measuring muscle mass is useful, but the amount of muscle someone has is not the same as how well that muscle works.
Strength and physical performance add another layer of information. This is why modern approaches to sarcopenia consider measures such as handgrip strength and chair-rise performance rather than defining muscle health solely from a body-composition scan.
A person can have a reasonable amount of lean tissue and still have poor muscle function. Conversely, improving strength can be clinically meaningful even when the change in measured lean mass is modest.
This distinction has become even more interesting with new research on sarcopenic obesity. A 2026 study following nearly 490,000 adults found that sarcopenic obesity and sarcopenia were associated with higher dementia risk, while declining handgrip strength was one of the most consistent predictors.
That study does not prove that muscle loss causes dementia, but it reinforces an important point: muscle health belongs in a much broader conversation about aging than fitness or appearance alone.
Read more: Sarcopenic Obesity and the Brain: Why Muscle Loss May Matter More Than Weight.
Visceral Fat Is Different From the Fat You Can See
Total body fat matters, but where fat is stored can matter even more.
Subcutaneous fat sits beneath the skin. Visceral fat accumulates deeper within the abdominal cavity around internal organs and is much more closely associated with insulin resistance, type 2 diabetes, fatty liver disease and cardiovascular risk.
A person does not have to appear obese to carry excess visceral fat. Someone with a relatively normal BMI can still have an unfavorable amount of abdominal visceral adipose tissue, particularly when muscle mass is low.
This is another reason visual appearance and scale weight are poor substitutes for measurement.
Learn more in Visceral Fat and Longevity: Why Hidden Fat Matters More Than Weight.
Lean Mass and Fat Mass Need to Be Considered Together
There is no single ideal body-fat percentage or lean-mass number that applies to everyone. Age, sex, height, frame size, training history, health status and clinical goals all matter.
The relationship between the compartments is often more informative than either one alone.
Someone losing excess fat while preserving lean tissue is moving in a different direction from someone losing both fat and substantial muscle. Someone gaining muscle while maintaining stable visceral fat may see the scale rise while becoming metabolically and functionally healthier.
This is the limitation of weight-centered thinking. It can label a physiologically beneficial change as failure and an unfavorable change as success.
For more detail, see Lean Mass vs Fat Mass: Why Weight Alone Misleads in Longevity Medicine.
DEXA: Seeing What the Scale Cannot
A whole-body DEXA scan provides an imaging-based assessment of body composition. In addition to bone-density testing, DEXA can measure total and regional lean mass, body-fat percentage, fat distribution and visceral adipose tissue.
Depending on the report, useful measurements may include:
- total fat mass
- total lean mass
- regional lean mass in the arms, legs and trunk
- appendicular lean mass
- android and gynoid fat distribution
- visceral adipose tissue
- bone mineral density
That makes DEXA useful for establishing a baseline and for answering practical questions that weight cannot answer. Is weight loss coming primarily from fat? Is lean tissue being preserved? Is visceral fat improving? Has muscle distribution changed? Is bone density also becoming a concern?
DEXA is not a complete assessment of muscle health because it measures tissue quantity rather than strength or physical performance. But as an objective measure of body composition, it gives us an excellent place to start.
Learn more about DEXA Bone Density, Body Composition & Visceral Fat Testing.
SECA: Following the Trend Between DEXA Scans
DEXA is useful for a detailed structural baseline, but there is rarely a reason to repeat an imaging study every few weeks during active weight loss or body recomposition.
SECA medical body-composition analysis gives us a practical way to monitor lean mass, fat mass, body water and related trends more frequently.
This is particularly useful during medically supervised weight loss, resistance training, significant nutrition changes or other treatment expected to alter body composition.
If weight is falling but lean mass is also declining more quickly than intended, we want to know that while there is still time to adjust the plan. Protein intake, resistance training, recovery, calorie intake and the rate of weight loss may all need to be reconsidered.
The value of serial testing is not collecting more numbers. It is identifying the direction of change.
Learn more about SECA Body Composition Analysis and Metabolic Tracking.
Body Composition and Metabolic Health
Muscle and adipose tissue have very different effects on metabolic physiology.
Skeletal muscle is a major destination for glucose after a meal. Maintaining adequate muscle and using it regularly through physical activity and resistance training helps support insulin sensitivity.
Visceral fat, by contrast, is closely associated with insulin resistance and other cardiometabolic abnormalities. As visceral fat increases and muscle declines, the metabolic picture can worsen even when total body weight changes very little.
This is one reason we frequently interpret body composition alongside fasting insulin, glucose, hemoglobin A1c, triglycerides, ApoB and other metabolic and cardiovascular markers.
Explore Metabolic Health and Insulin Resistance and Fasting Insulin and Metabolic Health.
Body Composition and Cardiovascular Risk
Body composition also belongs in a cardiovascular assessment.
Excess visceral fat commonly travels with insulin resistance, hypertension, higher triglycerides, fatty liver disease and an unfavorable atherogenic lipoprotein profile. Low physical activity and loss of muscle can compound the problem.
None of these measurements replaces direct cardiovascular risk assessment. A DEXA scan cannot tell us whether coronary plaque is present, and visceral fat does not substitute for ApoB, Lp(a), blood pressure or vascular imaging.
What body composition does provide is another piece of the physiology that can help explain why risk is developing and what may be modifiable.
Learn more about Preventive Cardiology at HormoneSynergy®.
Body Composition and Hormones
Hormones influence body composition, but the relationship runs in both directions and is rarely explained by one hormone level.
Testosterone contributes to lean mass and muscle strength in men and also has physiological roles in women. Estradiol influences muscle, bone, fat distribution and metabolic physiology. Thyroid function, insulin signaling and cortisol physiology can also affect weight, muscle and fat distribution.
At the same time, changes in body composition can alter hormone physiology. Visceral adiposity and insulin resistance can affect sex-hormone binding globulin, aromatase activity and the metabolic environment in which hormones are functioning.
This is why body-composition changes during menopause, andropause or hormone treatment should be evaluated in context. Hormones may be part of the explanation, but nutrition, training, sleep, metabolic health, medications and aging itself also matter.
Learn more about Hormone Optimization and Longevity Medicine.
Weight Loss Is Not Automatically Better Body Composition
This distinction has become particularly important in the GLP-1 era.
For appropriate patients, GLP-1 medications can produce substantial improvements in obesity, diabetes, insulin resistance and cardiovascular risk. But significant weight loss from any method, including medication, nutrition or bariatric surgery, can include some loss of lean tissue.
That does not make weight loss harmful. It means the quality of the weight loss matters.
If someone loses 30 pounds, we want to know how much came from excess fat, how much came from visceral fat and how much came from lean tissue. We also want to know whether strength is being maintained.
Protein intake, progressive resistance training and objective body-composition monitoring therefore belong alongside the medication when preservation of muscle is part of the clinical goal.
Read more about GLP-1s, Muscle Preservation, and the Future of Weight Loss.
Body Composition and Bone Health
Muscle and bone age together.
Resistance training and weight-bearing activity provide mechanical stimulus to both tissues. Loss of muscle and physical function can increase fall risk, while low bone density makes the consequences of a fall more serious.
DEXA is particularly useful in this setting because the same visit can provide information about both bone mineral density and whole-body composition.
A patient may come in primarily concerned about weight or visceral fat and discover low bone density. Another may be referred for bone-density testing and discover unexpectedly low lean mass. Looking at these systems together often reveals more than evaluating either one alone.
Body Composition and Brain Health
The connection between body composition and brain aging is an emerging area of research.
Metabolic dysfunction, diabetes, hypertension, vascular disease and physical inactivity are already part of the broader dementia-risk picture. Muscle may belong there as well.
A large 2026 prospective study found that sarcopenia and sarcopenic obesity were associated with higher dementia risk over long-term follow-up. Declining grip strength was one of the more consistent signals, while obesity without sarcopenia did not show the same relationship.
The study cannot prove that loss of muscle causes dementia. It does reinforce the idea that maintaining muscle and physical function may tell us something important about how the entire body is aging.
Explore Sarcopenic Obesity and the Brain: Why Muscle Loss May Matter More Than Weight.
What We Look at Clinically
There is no single body-composition number that defines healthy aging.
Depending on the individual and the reason for testing, we may be interested in:
- total and regional lean mass
- appendicular lean mass
- muscle distribution
- total fat mass and body-fat percentage
- visceral adipose tissue
- changes in lean mass during weight loss
- strength and physical function
- bone mineral density
- waist circumference
- fasting insulin and glucose regulation
- triglycerides and ApoB
- hormone and thyroid status when clinically relevant
- protein intake
- resistance-training history
We are also interested in trends. A single measurement provides a baseline. Repeated measurements tell us whether the plan is working.
The Goal Is Not a Particular Body Type
Body-composition medicine can become unhelpful very quickly if it turns into another way of telling people how they are supposed to look.
That is not the point.
The clinical goals are much more practical: maintain enough muscle to remain strong and metabolically resilient, limit harmful visceral fat, protect bone, preserve physical function and improve the risk factors that can actually be changed.
For one patient, success may mean losing a substantial amount of fat while maintaining lean mass. For another, it may mean gaining muscle even if body weight increases slightly. For an older adult, maintaining muscle and strength may be far more important than trying to reach a weight from decades earlier.
The right body-composition goal depends on the person in front of us.
Why Weight Alone Is Misleading
Weight still has a place. It is inexpensive, easy to follow and useful when interpreted correctly.
The problem comes when it is asked to answer questions it cannot answer.
A scale cannot tell us whether:
- weight loss came from fat or muscle
- visceral fat is improving
- muscle mass is declining with age
- strength is being preserved
- bone density is low
- a stable weight is hiding unfavorable body recomposition
This is why a person can reach a lower goal weight and still have work to do, while another person can weigh more and be metabolically and functionally healthier than before.
For a deeper discussion, read Body Composition and Longevity: Why Weight Alone Is Misleading.
Where Body Composition Fits in Longevity Medicine
Body composition is not a separate specialty sitting off to the side of longevity medicine. It intersects with nearly every major system we evaluate.
Muscle affects glucose regulation and physical reserve. Visceral fat affects metabolic and cardiovascular risk. Hormonal changes can alter muscle and fat distribution. Nutrition and exercise determine whether muscle is being maintained. Bone, muscle and physical function influence independence later in life. Emerging research also connects sarcopenia and body composition with cognitive aging.
That is why body composition is useful. It gives us objective information about several systems at once and gives us something meaningful to follow over time.
Frequently Asked Questions
What is body composition?
Body composition describes the tissues that make up body weight, including lean mass, fat mass, visceral fat and bone. It provides more useful information than weight alone because it shows what the body is actually made of.
Why is body composition important for longevity?
Muscle, visceral fat and fat distribution influence metabolic health, cardiovascular risk, physical function and the ability to remain independent with age. Body composition also helps show whether interventions such as weight loss or resistance training are changing the body in the intended direction.
What is visceral fat?
Visceral fat is fat stored within the abdominal cavity around internal organs. Higher levels are associated with insulin resistance, type 2 diabetes, fatty liver disease and cardiovascular risk.
What is the difference between lean mass and muscle mass?
Lean mass includes most non-fat, non-bone tissue and is therefore not exactly the same as skeletal muscle. DEXA regional and appendicular lean-mass measurements can be useful for estimating changes in muscle tissue, but muscle function and strength also need to be considered.
How is body composition measured?
HormoneSynergy® uses Hologic® DEXA for imaging-based assessment of lean mass, fat mass, fat distribution and visceral fat. SECA medical body-composition analysis can be used for more frequent monitoring of body-composition trends between DEXA scans.
Is BMI the same as body composition?
No. BMI is calculated from height and weight. It cannot determine how much of that weight comes from muscle or fat, how much visceral fat is present or whether someone is losing muscle over time.
Can I lose weight and still lose too much muscle?
Yes. Significant weight loss from nutrition changes, medication or surgery can include both fat and lean tissue. This is why adequate protein, progressive resistance training and body-composition monitoring can be useful during active weight loss.
Can body composition improve without much weight loss?
Yes. Someone may lose fat while gaining or preserving muscle, producing a meaningful improvement in body composition with relatively little change in total body weight.
Can DEXA diagnose sarcopenia?
DEXA can measure lean tissue and appendicular lean mass, which are useful when evaluating possible sarcopenia. Sarcopenia assessment also considers muscle strength and physical performance, so a DEXA scan alone does not provide the entire diagnosis.
Selected Clinical References
- Donini LM, Busetto L, Bischoff SC, et al. Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement. Obesity Facts. 2022.
- Cruz-Jentoft AJ, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing. 2019.
- Guan Z, Stephan BCM, Donini LM, et al. Sarcopenic obesity and dementia risk: Primary associations and landmark analyses of muscle strength and body composition trajectories. Clinical Nutrition. 2026.